PROTALIX BIOTHERAPEUTICS INC (PLX) Stock Analyst Earnings Estimates
NYSEARCA:PLX - NYSE Arca - US74365A3095 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 47.64M 24.22% | 65.494M 37.48% | 53.399M -18.47% | 58.741M 10.00% | 107.57M 83.13% | 163.21M 51.72% | |
| EBITDA YoY % growth | -11.92M 38.37% | 11.651M 197.74% | 5.221M -55.19% | N/A | N/A | N/A | |
| EBIT YoY % growth | -13.01M 36.41% | 10.46M 180.40% | 3.917M -62.55% | 37.72M 862.98% | 64.695M 71.51% | 101.56M 56.98% | |
| Operating Margin | -27.31% | 15.97% | 7.34% | 64.21% | 60.14% | 62.23% | |
| EPS YoY % growth | N/A 37.48% | 0.05 112.69% | 0.03 -40.00% | 0.31 943.67% | 0.85 170.97% | N/A |
All data in USD
| Q2 / 25 | Q3 / 25 | |
|---|---|---|
| EPS Q2Q % growth | 0.03 201.00% | 0.07 135.67% |
| Revenue Q2Q % growth | 13.681M 1.54% | 17.967M 0.04% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | 2.219M 191.43% | 5.262M 31.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.05 16.67% | 0.03 | -0.08 | -265.02% |
| Q4 2024 Q2Q % growth | 0.09 228.57% | 0.07 | 0.02 | 27.30% |
| Q3 2024 Q2Q % growth | 0.03 175.00% | 0.04 | -0.01 | -25.74% |
| Q2 2024 Q2Q % growth | -0.03 -114.29% | 0.02 | -0.05 | -248.51% |
| Q1 2024 Q2Q % growth | -0.06 -20.00% | -0.02 | -0.04 | -197.03% |
| Q4 2023 Q2Q % growth | -0.07 | -0.03 | -0.04 | -131.02% |
| Q3 2023 Q2Q % growth | -0.04 42.86% | -0.07 | 0.03 | 43.42% |
| Q2 2023 Q2Q % growth | 0.21 290.91% | -0.04 | 0.25 | 619.80% |
| Q1 2023 Q2Q % growth | -0.05 | % | ||
| Q4 2022 Q2Q % growth | -0.07 53.33% | -0.15 | 0.08 | 53.80% |
| Q3 2022 Q2Q % growth | -0.07 22.22% | -0.15 | 0.08 | 53.80% |
| Q2 2022 Q2Q % growth | -0.11 56.00% | -0.18 | 0.07 | 39.49% |
| Q1 2022 Q2Q % growth | -0.05 64.29% | -0.04 | -0.01 | -23.76% |
| Q4 2021 Q2Q % growth | -0.15 -1,600.00% | -0.11 | -0.04 | -35.01% |
| Q3 2021 Q2Q % growth | -0.09 35.71% | -0.12 | 0.03 | 25.74% |
| Q2 2021 Q2Q % growth | -0.25 -92.31% | -0.08 | -0.17 | -209.41% |
| Q1 2021 Q2Q % growth | -0.14 -240.00% | -0.17 | 0.03 | 18.46% |
| Q4 2020 Q2Q % growth | 0.01 -49.01% | -0.09 | 0.10 | 111.65% |
| Q3 2020 Q2Q % growth | -0.14 30.00% | -0.08 | -0.06 | -73.27% |
| Q2 2020 Q2Q % growth | -0.13 74.00% | -0.21 | 0.08 | 37.21% |
| Q1 2020 Q2Q % growth | 0.10 120.00% | -0.30 | 0.40 | 133.00% |
| Q4 2019 Q2Q % growth | 0.02 | -0.25 | 0.27 | 107.77% |
| Q3 2019 Q2Q % growth | -0.20 | -0.35 | 0.15 | 43.42% |
| Q2 2019 Q2Q % growth | -0.50 | -0.30 | -0.20 | -65.02% |
| Q1 2019 Q2Q % growth | -0.50 | -0.25 | -0.25 | -98.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | 10.113M 169.68% | 21.816M | -11.703M | -53.64% |
| Q4 2024 Q2Q % growth | 18.218M 73.74% | 18.941M | -723K | -3.82% |
| Q3 2024 Q2Q % growth | 17.959M 73.60% | 16.421M | 1.538M | 9.37% |
| Q2 2024 Q2Q % growth | 13.474M -61.59% | 12.625M | 849K | 6.72% |
| Q1 2024 Q2Q % growth | 3.75M -60.90% | 9.292M | -5.542M | -59.64% |
| Q4 2023 Q2Q % growth | 10.486M 21.65% | 5.858M | 4.628M | 79.00% |
| Q3 2023 Q2Q % growth | 10.345M -27.05% | 7.716M | 2.629M | 34.07% |
| Q2 2023 Q2Q % growth | 35.075M 300.86% | 10.324M | 24.751M | 239.74% |
| Q1 2023 Q2Q % growth | 9.59M -40.40% | % | ||
| Q4 2022 Q2Q % growth | 8.62M 0.82% | 6.181M | 2.439M | 39.46% |
| Q3 2022 Q2Q % growth | 14.18M 17.68% | 5.752M | 8.428M | 146.52% |
| Q2 2022 Q2Q % growth | 8.75M 36.08% | 2.702M | 6.048M | 223.83% |
| Q1 2022 Q2Q % growth | 16.09M 42.14% | 15.732M | 357.501K | 2.27% |
| Q4 2021 Q2Q % growth | 8.55M -56.15% | 7.868M | 682K | 8.67% |
| Q3 2021 Q2Q % growth | 12.05M 11.68% | 6.969M | 5.081M | 72.91% |
| Q2 2021 Q2Q % growth | 6.43M -41.39% | 8.383M | -1.953M | -23.30% |
| Q1 2021 Q2Q % growth | 11.32M -47.71% | 11.058M | 262K | 2.37% |
| Q4 2020 Q2Q % growth | 19.5M 9.80% | 12.107M | 7.393M | 61.06% |
| Q3 2020 Q2Q % growth | 10.79M -24.28% | 13.695M | -2.905M | -21.21% |
| Q2 2020 Q2Q % growth | 10.97M -10.45% | 10.982M | -12K | -0.11% |
| Q1 2020 Q2Q % growth | 21.65M 107.38% | 6.666M | 14.984M | 224.78% |
| Q4 2019 Q2Q % growth | 17.76M | 12.979M | 4.781M | 36.84% |
| Q3 2019 Q2Q % growth | 14.25M | 11.716M | 2.534M | 21.63% |
| Q2 2019 Q2Q % growth | 12.25M | 11.868M | 382K | 3.22% |
| Q1 2019 Q2Q % growth | 10.44M | 10.252M | 188K | 1.83% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -40% | 0% | 0% |
| Revenue | 0% | -41.36% | -33.34% | -33.34% |